Lets Learn The Right Use of PowerPoint
•
72 j'aime•25,637 vues
I addressed the students of the first batch of BIMTECH Bhubaneshawar in Greater NOIDA on Jan 04, 2014. While the topic was Using PowerPoint, I went beyond the software to cover fundamentals about the attention span of audience, why reading from slides leads to fragmented learning. I emphasised that PowerPoint is a tool and its more important to understand the art and then use the software in all its power (no pun intended.)
Recommandé
Recommandé
Contenu connexe
En vedette
En vedette (12)
Similaire à Lets Learn The Right Use of PowerPoint
Similaire à Lets Learn The Right Use of PowerPoint (20)
Plus de Mohit Chhabra
Plus de Mohit Chhabra (20)
Dernier
Dernier (20)
Lets Learn The Right Use of PowerPoint
- 1. Lets Learn Some Point ower P Mohit Chhabra !mohit_chhabra
- 3. PowerPoint is Evil! Sep 2003 Edward Tufte Data Visualization Pioneer Professor, Yale University
- 4. Ubiquitous
- 5. Class Room
- 6. Board Room
- 7. War Room
- 9. Evil
- 17. WHY?
- 21. Lets get active
- 23. What is a Presentation? !
- 24. Inform
- 25. Persuade
- 26. Entertain
- 27. Conversations
- 29. Persuade Inform
- 30. Persuade Inform
- 31. Persuade Inform
- 36. Text
- 37. Voice Text
- 38. Voice Text
- 43. PowerPoint Skills Learning to create better graphics in PowerPoint for amplifying your message
- 45. 3 things Subject. Learning to create better graphics
- 47. WHY?
- 55. Audiences remember very few things
- 58. Data, Figures, Pictures, Text
- 61. Big Idea
- 62. Strengthen
- 63. Graphs & Tables
- 64. Pictures
- 65. Diagrams
- 66. Progression
- 67. Graphs & Tables
- 68. Sales Compared to Competitors US$ 6,00,000 US$ 4,50,000 Pharma A Pharma B Pharma C Pharma D Pharma E Pharma F Pharma G Pharma H Pharma I US$ 3,00,000 US$ 1,50,000 December November October September August July US$ 0
- 69. Sales Compared 600 Pharma A Pharma D Pharma G Pharma H 450 300 150 0 600 450 300 150 0 July Aug Sep Oct Nov Dec July Aug Sep Oct Nov Dec Note: All figures in $ ‘000
- 70. Sales Compared 600 Pharma A Pharma D Pharma G Pharma H 450 300 150 0 600 450 Average Pharma E 300 150 0 July Aug Sep Oct Nov Dec July Aug Sep Oct Nov Dec Note: All figures in $ ‘000
- 71. Sales Compared July 2012 Aug 2012 Sep 2012 600 450 300 150 0 600 450 300 150 0 A D G Oct 2012 H E A D G H Nov 2012 E A D G H E Dec 2012 Note: All figures in $ ‘000
- 72. Unable to Gain Traction July 2012 600 Aug 2012 295 140 390 375 390 300 150 390 550 565 450 Sep 2012 245 153 145 95 142 110 100 0 600 570 450 465 570 460 550 385 300 255 188 150 190 185 262 200 80 90 65 0 A D G Oct 2012 H E A D G H Nov 2012 E A D G H E Dec 2012 Note: All figures in $ ‘000
- 73. How much bigger is the large circle than the small circle?
- 74. 16
- 75. Market Share Pharma Pharma G H Pharma F Pharma E Pharma A Pharma D Pharma C Pharma B
- 76. Market Share Pharma Pharma G H Pharma F 4% 1% 7% Pharma E 8% Pharma A 33% Pharma D 10% Pharma C 10% Pharma B 28%
- 77. Market Share
- 78. Market Share at the end of 2012 A 33 Our Co. 28 C 10 D 10 8 E 7 F 4 G H 1 Note: All figures in percent
- 79. Market Share at the end of 2012 A Our Co. C D E Others Note: All figures in percent
- 80. 73%
- 81. Purpose
- 86. What would you like to show?
- 87. Distribution What would you like to show?
- 88. Distribution What would you like to show? Composition
- 89. Distribution What would you like to show? Relationship Composition
- 90. Distribution Comparison What would you like to show? Relationship Composition
- 92. Select the appropriate statistical data
- 95. ‣ To show composition, usually ‣ 4 – 6 slices
- 96. ‣ To show composition, usually ! ‣ 4 – 6 slices ! ‣ Contrast with color or by exploding (or both!)
- 99. ‣ To show comparison ‣ Best used for a few periods of time
- 100. ‣ To show comparison ‣ Best used for a few periods of time ‣ Best if you limit the bars to 4-6
- 103. Used to demonstrate trends
- 105. ‣ To show comparison
- 106. ‣ To show comparison
- 107. Rs Year 1 REVENUES Year 2 4,02,66,240 EXPENSES Year 3 4,40,02,560 4,69,32,480 Manpower 1,24,92,000 1,37,41,200 1,51,15,320 Total Operating Expenses 53,12,400 1,18,28,840 1,25,07,204 Depreciation 18,24,000 10,94,400 6,56,640 2,95,50,000 0 0 4,91,78,400 2,66,64,440 2,82,79,164 Software cost amortized Total Losses carried forward EBIT Manpower (%age) EBIT (%age) -89,12,160 -89,12,160 84,25,960 1,86,53,316 31% 31% 32% -22% 19% 40%
- 108. Rs Year 1 Year 2 REVENUES 4,02,66,240 EXPENSES ! Manpower Year 3 4,40,02,560 4,69,32,480 !1,24,92,000 1,37,41,200 1,51,15,320 Total Operating Expenses 53,12,400 1,18,28,840 1,25,07,204 Depreciation 18,24,000 10,94,400 6,56,640 2,95,50,000 0 0 4,91,78,400 2,66,64,440 2,82,79,164 Too Detailed! Software cost amortized Total Losses carried forward EBIT Manpower (%age) EBIT (%age) ! -89,12,160 -89,12,160 84,25,960 1,86,53,316 31% 31% 32% -22% 19% 40%
- 109. Rs (lakh) Year 1 REVENUES Year 2 403 EXPENSES Year 3 440 469 Manpower 125 137 151 Total Operating Expenses 53 118 125 Depreciation 18 11 7 296 0 0 492 267 283 Software cost amortised Total Losses carried forward -89 EBIT -89 84 187 Manpower (as a %age) 31% 31% 32% -22% 19% 40% EBIT (as a %age)
- 110. Rs (lakh) Year 1 REVENUES 403 EXPENSES Manpower Year 3 440 469 125 151 118 125 18 ! 137 53 ! Total Operating Expenses Depreciation Year 2 11 7 Much Better! Software cost amortised 296 Losses carried forward EBIT Manpower (as a %age) EBIT (as a %age) 0 492 Total 0 267 283 ! -89 -89 84 187 31% 31% 32% -22% 19% 40%
- 111. Rs (lakh) Year 1 REVENUES 403 EXPENSES Manpower Year 3 440 469 125 151 118 125 18 ! 137 53 ! Total Operating Expenses Depreciation Year 2 11 7 Much Better! Software cost amortised 296 Losses carried forward EBIT Manpower (as a %age) EBIT (as a %age) 0 492 Total 0 267 283 ! -89 -89 84 187 31% 31% 32% -22% 19% 40% When the numbers are more important than the relationship
- 112. Data should be stripped to the ESSENTIALS
- 113. Revenue This Quarter 500 465 460 Value In Rs lakh 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Product Hylar Elexso Supra Microg Gemna Hylar Elexso
- 114. Revenue This Quarter 500 465 460 Value In Rs lakh 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Product Hylar Elexso Supra Microg Gemna Hylar Elexso
- 115. Revenue This Quarter 500 465 460 Value In Rs lakh 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Product Hylar Elexso Supra Microg Gemna Hylar Elexso
- 116. Revenue This Quarter 500 465 460 Value In Rs lakh 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Product Hylar Elexso Supra Microg Gemna Hylar Elexso
- 117. Revenue This Quarter 500 465 460 Value In Rs lakh 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Product Hylar Elexso
- 118. Revenue This Quarter 500 465 460 Value In Rs lakh 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Hylar Elexso
- 119. Revenue This Quarter 500 465 460 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Hylar Elexso
- 127. Q3 ’13 Revenues (in Rs lakh) 465 460 190 185 80 Supra Microg Gemna Hylar Elexso Source: Internal
- 128. Recap
- 129. Removed backgrounds
- 130. Removed extra labels
- 131. Removed borders and lines
- 132. Removed shadows, colors and effects
- 133. Simplified labels and title
- 134. Revenue This Quarter 500 465 460 Value In Rs lakh 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Product Hylar Elexso Supra Microg Gemna Hylar Elexso
- 135. Q3 ’13 Revenues (in Rs lakh) 465 460 190 185 80 Supra Microg Gemna Hylar Elexso Source: Internal
- 136. Data to Ink ratio
- 138. Pictures
- 141. Lasting Partnerships
- 145. Security! Text
- 146. Diagrams
- 147. 1 Network
- 148. 1 Network
- 149. 1 Network
- 150. 2 Segment
- 151. 2 Segment
- 152. 3 Flow
- 153. 3 Flow
- 154. 3 Flow
- 155. 3 Flow
- 156. 4 Join
- 157. 4 Join
- 158. 5 Stack
- 159. 5 Stack
- 160. 5 Stack
- 161. Progression
- 162. Revenue This Quarter 500 465 460 Value In Rs lakh 417 333 250 190 185 167 80 83 0 Supra Microg Gemna Product Hylar Elexso Supra Microg Gemna Hylar Elexso
- 163. Q3 ’13 Revenues (in Rs lakh) 465 460 190 185 80 Supra Microg Gemna Hylar Elexso Source: Internal
- 164. 15 slides
- 165. Performance Disruptive Technology gy g in ain ust h Tec lo no S Performance Oversupply anded t dem vement en pro m nce im ve erforma P o pr f im o ry to jec ra dt te Current performance of ec p Ex potentially disruptive technology t Time The sustaining technology has been disrupted
- 166. Performance Disruptive Technology Too red tte Clu gy g inin h Tec sta Su lo no Performance Oversupply anded t dem vement en pro m nce im ve erforma P o pr f im o ry to jec ra dt te Current performance of ec p Ex potentially disruptive technology t Time The sustaining technology has been disrupted
- 177. Performance Disruptive Technology Current performance of potentially disruptive technology t Time
- 182. Disruptive Technology Performance The sustaining technology has been disrupted t Time
- 183. This is Tom Peters and he is very intelligent!
- 184. You can use his quotes in your presentations! Tom Peters
- 186. Is it Actionable?
- 187. Is it Actionable? N
- 188. O
- 189. O DELETE it!
- 192. Is it Actionable? N
- 194. .
- 195. . DEFER it!
- 196. . DEFER it!
- 197. . DELEGATE it!
- 198. . DELEGATE it!
- 199. . DO it!
- 200. . DO it! Immediately
- 201. . DO it! Immediately To Do List